{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:16:50Z","timestamp":1789535810002,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022030","name":"Silence Therapeutics plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.molimm.2024.02.010","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T18:07:08Z","timestamp":1708193228000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy"],"prefix":"10.1016","volume":"168","author":[{"given":"Cristina","family":"Zanchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cerullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Aumiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Corna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlamaria","family":"Zoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2024.02.010_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/imr.13167","article-title":"Kidney diseases","volume":"313","author":"Daina","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2024.02.010_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/imr.13138","article-title":"With complements: C3 inhibition in the clinic","volume":"313","author":"Kolev","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2024.02.010_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2017.11.019","article-title":"Patterns of clinical response to eculizumab in patients with C3 glomerulopathy","volume":"72","author":"Le Quintrec","year":"2018","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.molimm.2024.02.010_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"10.1016\/j.molimm.2024.02.010_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MNH.0b013e32835da24c","article-title":"Treatment options for C3 glomerulopathy","volume":"22","author":"Nester","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.molimm.2024.02.010_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molimm.2024.02.010_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2024.02.010_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2024.02.010_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2018.12.046","article-title":"C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial","volume":"74","author":"Ruggenenti","year":"2019","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.molimm.2024.02.010_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2014121195","article-title":"Efficacy of targeted complement inhibition in experimental C3 glomerulopathy","volume":"27","author":"Ruseva","year":"2016","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.molimm.2024.02.010_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cei.12244","article-title":"C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo","volume":"176","author":"Ruseva","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2024.02.010_bib12","first-page":"179","article-title":"Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis","volume":"142","author":"Schulze","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2024.02.010_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2024.02.010_bib14","first-page":"1065","article-title":"Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury","volume":"22","author":"Sheerin","year":"2008","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.molimm.2024.02.010_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy - understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2024.02.010_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.omtn.2020.05.026","article-title":"Less is more: novel hepatocyte-targeted siRNA conjugates for treatment of liver-related disorders","volume":"21","author":"Weing\u00e4rtner","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.molimm.2024.02.010_bib17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1681\/ASN.2017091006","article-title":"An engineered complement factor H construct for treatment of C3 glomerulopathy","volume":"29","author":"Yang","year":"2018","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.molimm.2024.02.010_bib18","first-page":"1772","article-title":"Therapeutic small interfering RNA targeting complement C3 in a mouse model of C3 glomerulopathy","volume":"208","author":"Zanchi","year":"2022","journal-title":"J. Immunol. Baltim. Md 1950"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589024000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589024000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:46:51Z","timestamp":1758980811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589024000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":18,"alternative-id":["S0161589024000361"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2024.02.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2024.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}